This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Clinical Implications

Arch Ophthalmol. 2001;119:1710-1711.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE HUMAN Genome Project began as a joint initiative of the Department of Energy (Washington, DC) and the National Institutes of Health (Bethesda, Md) that was formed with the major goal of sequencing the DNA that defines the human genome. Since its conception, many other countries and public and private organizations (such as Celera) have participated in the massive task of sequencing approximately 3 billion base pairs of human DNA. Within this major objective were specific goals that included the identification of human DNA sequence variation and polymorphism as well as the identification of the chromosomal locations and sequence of all human genes.¹ It is well recognized that the Human Genome Project will lead to significant advances producing new definitions of human disease and that it will change the current practice of clinical medicine. During the past 5 years, most of the individual goals of the project have been realized.^2-3 . . . [Full Text of this Article]

IMPLICATIONS FOR HUMAN DISEASE


FINDING GENES RESPONSIBLE FOR EYE DISEASE

OUTLOOK FOR THE FUTURE